Beacon Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Sell
7,200
-14
-0.2% -$804 0.02% 198
2026
Q1
$438K Sell
7,214
-274
-4% -$16K 0.02% 194
2025
Q4
$404K Sell
7,488
-175
-2% -$8.42K 0.02% 193
2025
Q3
$346K Sell
7,663
-400
-5% -$18.7K 0.01% 205
2025
Q2
$373K Hold
8,063
0.02% 194
2025
Q1
$492K Buy
8,063
+212
+3% +$12.4K 0.02% 167
2024
Q4
$444K Sell
7,851
-300
-4% -$16.8K 0.02% 178
2024
Q3
$422K Sell
8,151
-1,500
-16% -$70.4K 0.02% 188
2024
Q2
$401K Sell
9,651
-249
-3% -$11.1K 0.02% 191
2024
Q1
$537K Sell
9,900
-3,287
-25% -$167K 0.02% 173
2023
Q4
$677K Sell
13,187
-7,983
-38% -$419K 0.03% 161
2023
Q3
$1.23M Sell
21,170
-600
-3% -$36.8K 0.06% 139
2023
Q2
$1.39M Sell
21,770
-4,625
-18% -$310K 0.06% 142
2023
Q1
$1.83M Sell
26,395
-115
-0.4% -$8.11K 0.09% 127
2022
Q4
$1.91M Sell
26,510
-717
-3% -$54.1K 0.1% 123
2022
Q3
$1.94M Buy
27,227
+242
+0.9% +$17.6K 0.11% 121
2022
Q2
$2.08M Buy
26,985
+55
+0.2% +$4.19K 0.11% 128
2022
Q1
$1.97M Sell
26,930
-694
-3% -$46.6K 0.08% 128
2021
Q4
$1.72M Sell
27,624
-3,176
-10% -$186K 0.07% 141
2021
Q3
$1.82M Sell
30,800
-3,265
-10% -$215K 0.08% 140
2021
Q2
$2.28M Sell
34,065
-1,396
-4% -$91K 0.09% 131
2021
Q1
$2.24M Buy
35,461
+1,000
+3% +$62.2K 0.1% 132
2020
Q4
$2.14M Buy
34,461
+395
+1% +$24.3K 0.1% 132
2020
Q3
$2.05M Buy
34,066
+102
+0.3% +$6.14K 0.11% 124
2020
Q2
$2M Sell
33,964
-74
-0.2% -$4.43K 0.11% 123
2020
Q1
$1.9M Buy
34,038
+252
+0.7% +$15.4K 0.13% 114
2019
Q4
$2.17M Buy
33,786
+21,453
+174% +$1.23M 0.12% 125
2019
Q3
$625K Sell
12,333
-1,400
-10% -$65.8K 0.06% 140
2019
Q2
$623K Sell
13,733
-17,551
-56% -$818K 0.07% 126
2019
Q1
$1.49M Sell
31,284
-24,665
-44% -$1.23M 0.16% 95
2018
Q4
$2.91M Sell
55,949
-2,998
-5% -$161K 0.32% 74
2018
Q3
$3.66M Sell
58,947
-5,746
-9% -$341K 0.36% 70
2018
Q2
$3.58M Sell
64,693
-2,638
-4% -$142K 0.36% 72
2018
Q1
$4.26M Buy
67,331
+18,231
+37% +$1.17M 0.44% 64
2017
Q4
$3.01M Sell
49,100
-3,092
-6% -$193K 0.32% 84
2017
Q3
$3.33M Buy
+52,192
New +$3.05M 0.29% 90
2016
Q3
Sell
-3,646
Closed -$268K 73
2016
Q2
$268K Buy
3,646
+73
+2% +$5.16K 0.06% 59
2016
Q1
$228K Hold
3,573
0.05% 59
2015
Q4
$246K Sell
3,573
-500
-12% -$33K 0.05% 55
2015
Q3
$241K Buy
+4,073
New +$258K 0.04% 55

Other funds holding BMY

Beacon Investment Advisory Services's BMY Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 0.19% in Q2 2026, selling an estimated $804 and leaving 7,200 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #198.

Beacon Investment Advisory Services first reported a position in BMY in Q3 2015 and has held it in 40 quarters since. The position peaked at $4.26M in Q1 2018. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Beacon Investment Advisory Services held 7,200 shares of Bristol-Myers Squibb worth $415K as of Q2 2026.
  • Beacon Investment Advisory Services sold 14 Bristol-Myers Squibb shares in Q2 2026, an estimated $804.
  • Bristol-Myers Squibb made up 0.02% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #198 holding.
  • Beacon Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 40 quarters since.
  • Beacon Investment Advisory Services's Bristol-Myers Squibb position peaked at $4.26M in Q1 2018.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.